Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Lik Sprava ; (2-3): 121-3, 1993.
Article in Russian | MEDLINE | ID: mdl-8191708

ABSTRACT

120 patients with chronic gastritis and primary chronic gastroduodenitis were given a three-week course of etiopathogenetic treatment (antichelibacterial and immunocorrective drugs) that allowed to diminish the clinical, bacteriological and immune manifestations of the disease and achieve a complete cure in most patients. Patients with marked chelibacteriosis revealed greater refractoriness. The authors recommend prolonged courses of treatment with alternations of etiologically directed drugs.


Subject(s)
Duodenitis/drug therapy , Gastritis/drug therapy , Adjuvants, Immunologic/therapeutic use , Adolescent , Adult , Anti-Bacterial Agents/therapeutic use , Antibodies, Bacterial/blood , Autoimmune Diseases/complications , Autoimmune Diseases/diagnosis , Autoimmune Diseases/drug therapy , Chronic Disease , Drug Therapy, Combination , Duodenitis/diagnosis , Duodenitis/etiology , Female , Gastritis/diagnosis , Gastritis/etiology , Helicobacter Infections/complications , Helicobacter Infections/diagnosis , Helicobacter Infections/drug therapy , Helicobacter pylori/immunology , Humans , Male , Middle Aged
2.
Vrach Delo ; (12): 61-3, 1990 Dec.
Article in Russian | MEDLINE | ID: mdl-2089805

ABSTRACT

Organ antibodies were studied after immunothermistometry treatment in 205 patients with chronic diseases of the liver. One group of patients was treated by routine methods in accordance with the diagnosis, while the second group of patients was additionally given hemodes. Before treatment organ antibodies were revealed in 31 patients (70.4%) with liver cirrhosis, in 44 (55%) with chronic hepatitis and 45 (55.5%) in chronic pancreatitis. After treatment these were respectively 9 (20.5%), 15 (18.7%) and 15 (18.5%). Depending on the treatment antibodies were more frequently eliminated in the first group of patients in chronic hepatitis. In liver cirrhosis and chronic pancreatitis there was no significant difference between the two groups of patients.


Subject(s)
Autoantibodies/blood , Liver Diseases/immunology , Liver/immunology , Pancreas/immunology , Pancreatic Diseases/immunology , Chronic Disease , Female , Humans , Liver Diseases/therapy , Male , Pancreatic Diseases/therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...